ClinicalTrials.Veeva

Menu

the Efficency and Safety of Stretta in GERD

C

Capital Medical University

Status

Unknown

Conditions

Radiofrequency Ablation
GERD

Treatments

Device: Stretta

Study type

Observational

Funder types

Other

Identifiers

NCT03574831
xhnk001

Details and patient eligibility

About

This study evaluated the efficency and safety of the endoscopic radiofrequency procedure(Stretta) in adult gastroesophageal patients.

Full description

Gastro-esophageal reflux disease (GERD) is the most common outpatient diagnosis in gastroenterology and is associated with a significant burden on the healthcare system. Proton pump inhibitors (PPIs) are the mainstay of GERD treatment,howerver, some patients have an unsatisfactory response to high doses of PPIs, which remains a challenge. The Stretta procedure, a radiofrequency (RF) application to the lower esophageal sphincter (LES), was introduced about 15 years ago as an alternative to chronic medical therapy or surgical intervention for GERD.The Stretta procedure appears to result in thickening of the LES, decreased transient LES relaxation rate and reduced esophageal acid exposure.The majority studies of Stretta were held in USA and Europe, the sduty of Stretta in Asia is rare. The investigators propose to perform a prospectively observiton study to evaluate the efficency of the Stretta procedure in patients of refractory GERD in China.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age > 18 years
  2. Small hiatus hernia (< 2-3 cm)
  3. Los Angeles Grade 'A' or 'B' Reflux Esophagitis or non erosive esophagitis
  4. LES pressure <15 mm Hg
  5. PPI dependent / refractory GERD
  6. abnormal 24h esophagus pH-impedance monitoring

Exclusion criteria

  1. Age < 18 years
  2. Large hiatus hernia (> 3 cm)
  3. Los Angeles Grade 'C' or 'D' Reflux Esophagitis
  4. LES pressure > 15 mm Hg
  5. Underlying coagulation disorder
  6. Previous Esophageal or Gastric surgery
  7. Pregnant
  8. major esophagus motility disorder according to Chicago v3.0

Trial design

60 participants in 1 patient group

Stretta
Description:
Radio Frequency Ablation (RFA) using a Stretta device.
Treatment:
Device: Stretta

Trial contacts and locations

1

Loading...

Central trial contact

Hao Zi Guo, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems